We and others have demonstrated that PLK1 is a potential therapeutic target for brain tumors such as glioblastoma, medulloblastoma, and diffuse intrinsic pontine glioma (DIPG) [13-16]. The gene discussed is PLK1; the disease is diffuse intrinsic pontine glioma.